How MIT’s Bacterial CRISPR Finds Slash Gene R&D Costs for SMEs
MIT’s computational sweep of bacterial genomes unearthed hundreds of potential molecular scissors like CRISPR that could turbocharge biotech, empower garage biohackers, and upend industry rules. Discover how cheap, rapid discovery meets costly validation, why startups and regulators race, and what this means for small labs, markets, and shadowy cyberpunk futures.